Amadeus Capital Partners invierte en Igenomix
08/08/2016 AMADEUS CAPITAL PARTNERS INVIERTE EN IGENOMIX. Amadeus Capital Partners, the global technology investor, today announces that it has made a growth capital investment in Igenomix, the world´s leading in-vitro fertilization (IVF) genetic testing company, based in Valencia, Spain. Igenomix´s main customers are the most reputable providers of fertility treatments across the world. Its genetic…